These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 8056181)

  • 21. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Maxfield EK
    Diabetologia; 1993 Apr; 36(4):299-304. PubMed ID: 8477873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a potent new aldose reductase inhibitor, (5-(3-thienyltetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats.
    Hotta N; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K
    Diabetes Res Clin Pract; 1995 Feb; 27(2):107-17. PubMed ID: 7607048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in endoneurial blood flow, motor nerve conduction velocity and vascular relaxation of epineurial arterioles of the sciatic nerve in ZDF-obese diabetic rats.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
    Diabetes Metab Res Rev; 2002; 18(1):49-56. PubMed ID: 11921418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurovascular effects of L-carnitine treatment in diabetic rats.
    Cameron NE; Cotter MA
    Eur J Pharmacol; 1997 Jan; 319(2-3):239-44. PubMed ID: 9042596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na(+)-K(+)-ATPase activity, and vascular supply in STZ-D rats.
    Cameron NE; Cotter MA; Ferguson K; Robertson S; Radcliffe MA
    Diabetes; 1991 Dec; 40(12):1652-8. PubMed ID: 1661693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of abnormalities in motor nerve conduction and nerve blood-flow by a prostacyclin analog, beraprost sodium, in streptozotocin-induced diabetic rats.
    Hotta N; Koh N; Sakakibara F; Nakamura J; Hamada Y; Wakao T; Hara T; Mori K; Naruse K; Nakashima W
    Prostaglandins; 1995 Jun; 49(6):339-49. PubMed ID: 7480803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats.
    Cameron NE; Cotter MA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):607-14. PubMed ID: 12743678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glutathione and alpha-lipoate in diabetic rats: nerve function, blood flow and oxidative state.
    van Dam PS; van Asbeck BS; Van Oirschot JF; Biessels GJ; Hamers FP; Marx JJ
    Eur J Clin Invest; 2001 May; 31(5):417-24. PubMed ID: 11380593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of treating streptozotocin-induced diabetic rats with sorbinil, myo-inositol or aminoguanidine on endoneurial blood flow, motor nerve conduction velocity and vascular function of epineurial arterioles of the sciatic nerve.
    Coppey LJ; Gellett JS; Davidson EP; Dunlap JA; Yorek MA
    Int J Exp Diabetes Res; 2002; 3(1):21-36. PubMed ID: 11900277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the NAD(P)H oxidase inhibitor, apocynin, on peripheral nerve perfusion and function in diabetic rats.
    Cotter MA; Cameron NE
    Life Sci; 2003 Aug; 73(14):1813-24. PubMed ID: 12888120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost.
    Cotter MA; Dines KC; Cameron NE
    Naunyn Schmiedebergs Arch Pharmacol; 1993 May; 347(5):534-40. PubMed ID: 7686634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats.
    Cameron NE; Cotter MA; Hohman TC
    Diabetologia; 1996 Feb; 39(2):172-82. PubMed ID: 8635669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the sulphydryl donor N-acetyl-L-cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats.
    Love A; Cotter MA; Cameron NE
    Eur J Clin Invest; 1996 Aug; 26(8):698-706. PubMed ID: 8872067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Niceritrol prevents the decrease in red blood cell 2,3-diphosphoglycerate and neuropathy in streptozotocin-induced diabetic rats.
    Hotta N; Nakamura J; Kakuta H; Fukasawa H; Koh N; Sakakibara F; Mori K; Sakamoto N
    J Diabetes Complications; 1995; 9(3):133-9. PubMed ID: 7548976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids.
    Karasu C; Dewhurst M; Stevens EJ; Tomlinson DR
    Diabetologia; 1995 Feb; 38(2):129-34. PubMed ID: 7713308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy.
    Tuck RR; Schmelzer JD; Low PA
    Brain; 1984 Sep; 107 ( Pt 3)():935-50. PubMed ID: 6478183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The neurocytokine, interleukin-6, corrects nerve dysfunction in experimental diabetes.
    Cameron NE; Cotter MA
    Exp Neurol; 2007 Sep; 207(1):23-9. PubMed ID: 17560573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depletion of taurine in experimental diabetic neuropathy: implications for nerve metabolic, vascular, and functional deficits.
    Pop-Busui R; Sullivan KA; Van Huysen C; Bayer L; Cao X; Towns R; Stevens MJ
    Exp Neurol; 2001 Apr; 168(2):259-72. PubMed ID: 11259114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.
    Cotter MA; Cameron NE; Hohman TC
    J Peripher Nerv Syst; 1998; 3(3):217-23. PubMed ID: 10959252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.